232 related articles for article (PubMed ID: 26454758)
21. Compared to warfarin, direct oral anticoagulants are associated with lower mortality in patients with blunt traumatic intracranial hemorrhage: A TQIP study.
Feeney JM; Santone E; DiFiori M; Kis L; Jayaraman V; Montgomery SC
J Trauma Acute Care Surg; 2016 Nov; 81(5):843-848. PubMed ID: 27602897
[TBL] [Abstract][Full Text] [Related]
22. Intracranial Hemorrhage Caused by Non-Vitamin K Antagonist Oral Anticoagulants (NOACs)- Multicenter Retrospective Cohort Study in Japan.
Saji N; Kimura K; Aoki J; Uemura J; Sakamoto Y
Circ J; 2015; 79(5):1018-23. PubMed ID: 25739470
[TBL] [Abstract][Full Text] [Related]
23. A three-year prospective study of the presentation and clinical outcomes of major bleeding episodes associated with oral anticoagulant use in the UK (ORANGE study).
Green L; Tan J; Morris JK; Alikhan R; Curry N; Everington T; Maclean R; Saja K; Stanworth S; Tait C; MacCallum P
Haematologica; 2018 Apr; 103(4):738-745. PubMed ID: 29371325
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
Graham DJ; Reichman ME; Wernecke M; Zhang R; Southworth MR; Levenson M; Sheu TC; Mott K; Goulding MR; Houstoun M; MaCurdy TE; Worrall C; Kelman JA
Circulation; 2015 Jan; 131(2):157-64. PubMed ID: 25359164
[TBL] [Abstract][Full Text] [Related]
25. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
; Büller HR; Décousus H; Grosso MA; Mercuri M; Middeldorp S; Prins MH; Raskob GE; Schellong SM; Schwocho L; Segers A; Shi M; Verhamme P; Wells P
N Engl J Med; 2013 Oct; 369(15):1406-15. PubMed ID: 23991658
[TBL] [Abstract][Full Text] [Related]
26. Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding.
Little DHW; Sutradhar R; Cerasuolo JO; Perez R; Douketis J; Holbrook A; Paterson JM; Gomes T; Siegal DM
CMAJ; 2021 Mar; 193(9):E304-E309. PubMed ID: 33649169
[TBL] [Abstract][Full Text] [Related]
27. Between a rock and a hard place: resumption of oral anticoagulant therapy after intracranial hemorrhage.
Grainger BT; McFadyen JD; Tran H
J Thromb Haemost; 2024 Mar; 22(3):594-603. PubMed ID: 37913910
[TBL] [Abstract][Full Text] [Related]
28. Resuming anticoagulants after anticoagulation-associated intracranial haemorrhage: systematic review and meta-analysis.
Zhou Z; Yu J; Carcel C; Delcourt C; Shan J; Lindley RI; Neal B; Anderson CS; Hackett ML
BMJ Open; 2018 May; 8(5):e019672. PubMed ID: 29764874
[TBL] [Abstract][Full Text] [Related]
29. Management of intracranial hemorrhage in patients with left ventricular assist devices.
Wilson TJ; Stetler WR; Al-Holou WN; Sullivan SE; Fletcher JJ
J Neurosurg; 2013 May; 118(5):1063-8. PubMed ID: 23451903
[TBL] [Abstract][Full Text] [Related]
30. Anticoagulation Resumption After Intracerebral Hemorrhage.
Li YG; Lip GYH
Curr Atheroscler Rep; 2018 May; 20(7):32. PubMed ID: 29781063
[TBL] [Abstract][Full Text] [Related]
31. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
[TBL] [Abstract][Full Text] [Related]
32. Optimal Timing for Resumption of Anticoagulation After Intracranial Hemorrhage in Patients With Mechanical Heart Valves.
Barra ME; Forman R; Long-Fazio B; Merkler AE; Gurol ME; Izzy S; Sharma R
J Am Heart Assoc; 2024 May; 13(10):e032094. PubMed ID: 38761076
[TBL] [Abstract][Full Text] [Related]
33. Dabigatran Use Does Not Increase Intracranial Hemorrhage in Traumatic Geriatric Falls When Compared with Warfarin.
Pozzessere A; Grotts J; Kaminski S
Am Surg; 2015 Oct; 81(10):1039-42. PubMed ID: 26463304
[TBL] [Abstract][Full Text] [Related]
34. Use of blood products in patients with anticoagulant-related major bleeding: an analysis of inhospital outcomes.
Menzin J; Sussman M; Nichols C; Friedman M; Zbrozek A
Am J Health Syst Pharm; 2014 Oct; 71(19):1635-45. PubMed ID: 25225449
[TBL] [Abstract][Full Text] [Related]
35. Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk.
Phan TG; Koh M; Wijdicks EF
Arch Neurol; 2000 Dec; 57(12):1710-3. PubMed ID: 11115236
[TBL] [Abstract][Full Text] [Related]
36. Vitamin K antagonist-associated intracerebral hemorrhage: lessons from a devastating disease in the dawn of the new oral anticoagulants.
Suárez-Pinilla M; Fernández-Rodríguez Á; Benavente-Fernández L; Calleja-Puerta S
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):732-42. PubMed ID: 23954605
[TBL] [Abstract][Full Text] [Related]
37. Risk of thromboembolism with short-term interruption of warfarin therapy.
Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
[TBL] [Abstract][Full Text] [Related]
38. Between Scylla and Charybdis: risks of early therapeutic anticoagulation for venous thromboembolism after acute intracranial hemorrhage.
Nguyen T; Sharma M; Crooks P; Patel PV; Bonow RH; Creutzfeldt CJ; Wahlster S
Br J Neurosurg; 2022 Apr; 36(2):251-257. PubMed ID: 35343356
[TBL] [Abstract][Full Text] [Related]
39. Predictors of outcome in warfarin-related intracerebral hemorrhage.
Zubkov AY; Mandrekar JN; Claassen DO; Manno EM; Wijdicks EF; Rabinstein AA
Arch Neurol; 2008 Oct; 65(10):1320-5. PubMed ID: 18852345
[TBL] [Abstract][Full Text] [Related]
40. Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall.
Gage BF; Birman-Deych E; Kerzner R; Radford MJ; Nilasena DS; Rich MW
Am J Med; 2005 Jun; 118(6):612-7. PubMed ID: 15922692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
